EMMA EMS: Open Payments
NPI 1548614647 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 8 payments from 8 companies in 2025. Trend: 2023 $768 · 2024 $524 · 2025 $752
Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $126 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Apellis Pharmaceuticals, Inc. | 1 | $120 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Solventum Corporation | 1 | $100 |
| Ceribell, Inc. | 1 | $75 |
| Amgen Inc. | 1 | $69 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
Products named: Korlym, INGREZZA, Empaveli, REXULTI, V.A.C. VERAFLO, POCKET EEG DEVICE, EVENITY, Natroba.
Industry payments across FL — which companies pay providers there.
